Press releases about sanofi-aventis: clinical studies, financial and company announcements, R&D initiatives, as well as developments in the local site.

Contact

Our media contact is:

The Communications Manager
sanofi-aventis Philippines, Inc.
3F Feliza Bldg.
108 V. A. Rufino St., Legaspi Village,
1229 Makati City, Philippines

Tel: (632) 859-5555
Fax: (632) 813-1676

Press Room

Press releases are intended for journalists, investors and shareholders.

Our Press Room includes headline news about our Group, products, R&D initiatives, as well as developments in the local site.
Recognising the importance of good communications with both the general public and healthcare professionals, we value our relationships with all media representatives.

As a fast growing pharmaceutical company, sanofi-aventis maintains particularly strong links with key press and broadcast organizations.

July 01, 2010

Rifapentine is granted Orphan Drug Status by European Commission for Treatment of Tuberculosis

Shorter treatment duration with rifapentine expected to bring significant benefits to patients

Download

July 01, 2010

Sanofi-aventis and JDRF Form Partnership to Improve Therapies, Work Toward Cure for Type 1 Diabetes

Download

Corporate Information
Explore our Corporate Press room